๐Ÿงช Beta โ€” BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

ct vs su

Mechanistic comparison of ct 7001 and su 9516 based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

4
Shared Targets
29%
Jaccard Similarity
28%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

ct 7001
โ€”
Evidence Score
0
PubMed Studies
View full profile โ†’
su 9516
โ€”
Evidence Score
0
PubMed Studies
View full profile โ†’

Target Overlap

ct and su share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 โ‰ค 10 ยตM) and ChEMBL. A Jaccard index of 0.286 means 29% of the combined target set is bound by both compounds. The IDF-weighted score of 0.276 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do ct and su have in common?
ct and su share 4 molecular targets with a Jaccard similarity of 29%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can ct and su be combined?
ct and su share 4 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: ct or su?
In the BiohacksAI corpus: ct has 0 PubMed-indexed studies, su has 0 studies.

Related Comparisons

Similar to ct

ct vs voruciclib7 targetsct vs s5 targetsct vs roniciclib5 targetsct vs cyc4 targetsct vs ebvaciclib4 targets

Similar to su

su vs voruciclib4 targetssu vs roniciclib4 targetssu vs s3 targetssu vs olomoucine3 targetssu vs ebvaciclib3 targets
View full ct profile โ†’View full su profile โ†’Browse all substances โ†’